Fundraising FoxNano Precision Medical
Emeryville, US · Founded 2009 · California corporation
Find your way into Nano Precision Medical
Sign up to see every warm intro you have to Nano Precision Medical
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Nano Precision Medical team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
Nano Precision Medical was founded in 2009 by Adam Mendelsohn.
AM
Adam MendelsohnFounder
LP
Lily PengExecutiveLily Peng worked as a Research Assistant at Beth Israel Deaconess Medical Center with a background in data science. She is an Executive Officer at Nano Precision Medical.
Board
AM
Aaron MendelsohnBoard director
WD
W. Dean BakerBoard director
Reported raises · per SEC filings
Form D private placements$12.9M disclosed across 7 rounds · 2011–2015
▶$2.4MraisedFeb 2016 · 20 investors · BiotechnologyRule 506(b)
▶$2.4MraisedFeb 2016 · 20 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Adam MendelsohnExecutive Officer, Director
- Kathleen FischerExecutive Officer, Director
- W. Dean BakerDirector
- Aaron MendelsohnDirector
- Lily PengExecutive Officer, Director
- Offering amount
- $2.4M
- Amount sold
- $2.4M
- Minimum investment
- $1K
- First sale
- Jan 2014
- Incorporated
- Corporation, California
- Federal exemptions
- 06b
▶$2.5MraisedFeb 2016 · 20 investors · BiotechnologyRule 506(b)
▶$2.5MraisedFeb 2016 · 20 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Aaron MendelsohnDirector
- Adam MendelsohnExecutive Officer, Director
- Kathleen FischerExecutive Officer, Director
- Lily PengExecutive Officer, Director
- W. Dean BakerDirector
- Offering amount
- $2.5M
- Amount sold
- $2.5M
- Minimum investment
- $1K
- First sale
- Nov 2011
- Incorporated
- Corporation, California
- Federal exemptions
- 06b
▶$5.7MraisedFeb 2016 · 40 investors · BiotechnologyRule 506(b)
▶$5.7MraisedFeb 2016 · 40 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- AARON MENDELSOHNDirector
- ADAM MENDELSOHNExecutive Officer, Director
- LILY PENGExecutive Officer
- W. DEAN BAKERDirector
- KATHLEEN FISCHERExecutive Officer
- Offering amount
- $5.7M
- Amount sold
- $5.7M
- Minimum investment
- $1K
- Proceeds to insiders
- $200K
- First sale
- Apr 2015
- Incorporated
- Corporation, California
- Federal exemptions
- 06b
▶$250KraisedFeb 2016 · 2 investors · BiotechnologyRule 506(b)
▶$250KraisedFeb 2016 · 2 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Lily PengExecutive Officer
- Adam MendelsohnExecutive Officer, Director
- W. Dean BakerDirector
- Aaron MendelsohnDirector
- Kathleen FischerExecutive Officer
- Offering amount
- $250K
- Amount sold
- $250K
- Minimum investment
- $1K
- Proceeds to insiders
- $50K
- First sale
- Oct 2014
- Incorporated
- Corporation, California
- Federal exemptions
- 06b
▶$70KraisedFeb 2016 · 2 investors · BiotechnologyRule 506(b)
▶$70KraisedFeb 2016 · 2 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Adam MendelsohnExecutive Officer, Director
- W. Dean BakerDirector
- Aaron MendelsohnDirector
- Lily PengExecutive Officer
- Kathleen FischerExecutive Officer
- Offering amount
- $250K
- Amount sold
- $70K
- Minimum investment
- $1K
- Proceeds to insiders
- $50K
- First sale
- Aug 2013
- Incorporated
- Corporation, California
- Federal exemptions
- 06b
▶$40KraisedFeb 2016 · 1 investors · BiotechnologyRule 506(b)
▶$40KraisedFeb 2016 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Aaron MendelsohnDirector
- Lily PengExecutive Officer
- Kathleen FischerExecutive Officer
- Adam MendelsohnExecutive Officer, Director
- W. Dean BakerDirector
- Offering amount
- $100K
- Amount sold
- $40K
- Minimum investment
- $1K
- Proceeds to insiders
- $10K
- First sale
- Feb 2014
- Incorporated
- Corporation, California
- Federal exemptions
- 06b
▶$2MraisedMar 2014 · 4 investors · BiotechnologyRule 506(b)
▶$2MraisedMar 2014 · 4 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Adam MendelsohnExecutive Officer, Director
- Kathleen FischerExecutive Officer, Director
- W. Dean BakerDirector
- Aaron MendelsohnDirector
- Lily PengExecutive Officer, Director
- Offering amount
- $2M
- Amount sold
- $2M
- Minimum investment
- $1K
- Proceeds to insiders
- $200K
- First sale
- Feb 2011
- Incorporated
- Corporation, California, 2009
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- Who founded Nano Precision Medical?
- Nano Precision Medical was founded by Adam Mendelsohn in 2009.
- How much funding has Nano Precision Medical raised?
- Nano Precision Medical has disclosed $12.9M raised across 7 rounds.
- Where is Nano Precision Medical headquartered?
- Nano Precision Medical is headquartered in Emeryville, US.